Recombinant Legionella pneumophila Ribonuclease 3 (rnc)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary based on purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. For dry ice shipping, contact us in advance; extra fees apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
rnc; LPC_1314; Ribonuclease 3; EC 3.1.26.3; Ribonuclease III; RNase III
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-224
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Legionella pneumophila (strain Corby)
Target Names
rnc
Target Protein Sequence
MKINLERLCR RLNYHFNNIA YLKQALTHCS AGSDNYERFE FLGDSILSFV IANELFNRFP LHSEGQLSRL RSFLVKGEML AEIAREIGLG DYLFLGQGEL RSGGFRRTSI LADALEAILA AIYLDGGMTA AKQIILMLYS SRLDDPDLNH CLKDAKTQLQ EFLQASKFAL PEYVLTKIEG DEHAQIFHVT CTIEGVSQVA YGTGPNRRKA EQLAAKAMLE QLQG
Uniprot No.

Target Background

Function
Digests double-stranded RNA. Involved in processing rRNA transcripts into precursors for large (23S) and small (16S) rRNAs. Processes some mRNAs and tRNAs when encoded in the rRNA operon. Also processes pre-crRNA and tracrRNA of type II CRISPR loci if present.
Database Links

KEGG: lpc:LPC_1314

Protein Families
Ribonuclease III family
Subcellular Location
Cytoplasm.

Q&A

What is Ribonuclease III (rnc) in Legionella pneumophila and what is its functional importance?

Ribonuclease III (rnc) in Legionella pneumophila is an endoribonuclease that belongs to the RNase III family of enzymes, which are responsible for processing double-stranded RNA. Research has demonstrated that Ribonuclease III plays crucial roles in multiple cellular processes including rRNA maturation and post-transcriptional regulation. Studies have shown that RNase III is involved in the maturation of 30S rRNA and in the regulation of PNPase production . The enzyme appears to retain some conserved functions common to the RNase III family across different bacterial species while also possessing unique characteristics that may be specifically adapted to L. pneumophila's lifestyle.

How does Ribonuclease III differ from other ribonucleases in Legionella pneumophila?

Ribonuclease III is functionally distinct from other ribonucleases in L. pneumophila in several important ways:

RibonucleaseTypeSubstrate SpecificityPrimary Functions
RNase III (rnc)EndoribonucleaseDouble-stranded RNArRNA processing, mRNA regulation, sRNA processing
RNase R3'–5' ExoribonucleaseSingle-stranded RNARNA degradation, competence development

Unlike RNase III, RNase R is a processive 3'–5' exoribonuclease that degrades RNA from the 3' end. Interestingly, L. pneumophila possesses RNase R as its only hydrolytic 3'–5' exoribonuclease , while many other bacteria have additional exoribonucleases like RNase II. RNase III functions by internal cleavage of RNA molecules, whereas RNase R progressively degrades RNA from one end. These enzymes serve complementary but distinct roles in RNA metabolism and gene regulation.

What roles does Ribonuclease III play in the lifecycle and pathogenicity of Legionella pneumophila?

While research directly linking Ribonuclease III to L. pneumophila pathogenicity is still developing, several important roles have been identified or inferred:

  • RNA maturation: RNase III is involved in the processing of ribosomal RNA, particularly 30S rRNA maturation

  • Gene regulation: Through its ability to cleave double-stranded RNA structures, RNase III likely regulates the expression of various genes

  • Environmental adaptation: Studies suggest RNase III might be a "main player in the survival of this pathogen to environmental demands"

  • Small RNA regulation: Similar to its role in other bacteria, RNase III may regulate small non-coding RNAs that control virulence factors

Research indicates that RNase III has complementary functions to other ribonucleases. For example, in other bacteria like Salmonella, RNase III cleaves the small non-coding RNA MicA when it is hybridized with its mRNA target, while RNase E degrades free MicA sRNA . This suggests a sophisticated interplay between different ribonucleases in regulating gene expression.

What are the optimal methods for expression and purification of recombinant Legionella pneumophila Ribonuclease III?

Based on established protocols for ribonucleases and available recombinant systems, the following methods are recommended:

Expression Systems:

  • E. coli expression systems (most common and efficient)

  • Yeast, baculovirus, or mammalian cell systems for specific requirements

Recommended Protocol:

  • Clone the full-length rnc gene (coding for amino acids 1-224) into an appropriate expression vector with a histidine tag

  • Transform into an RNase-deficient E. coli strain to prevent contamination with host ribonucleases

  • Induce expression using IPTG or auto-induction media

  • Harvest cells and lyse using sonication in a buffer containing RNase inhibitors

  • Purify using immobilized metal affinity chromatography (IMAC)

  • Further purify using ion-exchange chromatography to remove nucleic acid contaminants

  • Perform size exclusion chromatography for final polishing

  • Verify purity by SDS-PAGE and activity using RNA cleavage assays

Critical Considerations:

  • Maintain RNase-free conditions throughout purification

  • Include metal ions (typically Mg²⁺) in buffers as they are essential for RNase III activity

  • Consider expressing catalytic mutants as negative controls for activity assays

Robust characterization of RNase III activity requires multiple complementary approaches:

Standard Activity Assays:

  • Gel-based assays: Incubate purified enzyme with labeled RNA substrates and analyze cleavage products by denaturing PAGE

  • Fluorescence-based assays: Use fluorophore-quencher labeled RNA substrates that release measurable fluorescence upon cleavage

  • Circular dichroism: Monitor structural changes in RNA substrates upon enzyme activity

Kinetic Characterization:

  • Determine Michaelis-Menten parameters (Km, Vmax, kcat) using varying substrate concentrations

  • Assess the effects of pH, temperature, and ionic conditions on enzyme activity

  • Evaluate metal ion dependencies, particularly Mg²⁺ concentration effects

Substrate Specificity Analysis:

  • Test various structured RNA molecules including synthetic hairpins and natural substrates

  • Perform RNA footprinting to identify precise cleavage sites

  • Use mutational analysis of catalytic residues to confirm the conservation of the catalytic mechanism

What is the relationship between Ribonuclease III activity and gene expression regulation in Legionella pneumophila?

RNase III likely plays crucial roles in regulating gene expression through several mechanisms:

  • Direct mRNA regulation: By cleaving double-stranded regions in mRNA structures, RNase III can modulate transcript stability and translation efficiency.

  • sRNA-mediated regulation: Similar to what has been observed in Salmonella, RNase III may cleave small non-coding RNAs when they are hybridized with their mRNA targets, functioning as part of a "gene silencing" mechanism reminiscent of eukaryotic RNA interference .

  • rRNA processing: The role of RNase III in 30S rRNA maturation directly impacts ribosome assembly and function, with downstream effects on global protein synthesis.

  • Stress response modulation: RNase III may influence the expression of genes involved in adaptation to environmental stresses, potentially including those encountered during host infection.

Research has shown that in other bacteria, RNase III can work cooperatively with other ribonucleases like RNase E to achieve "fine-tuned control of post-transcriptional regulators" . This suggests a complex regulatory network involving multiple RNA processing enzymes.

How does Ribonuclease III potentially contribute to adaptation and virulence in Legionella pneumophila?

While direct evidence linking RNase III to L. pneumophila virulence is limited in the available literature, several potential mechanisms can be hypothesized based on its known functions:

  • Regulation of virulence factors: RNase III may process mRNAs encoding virulence factors or regulatory proteins that control their expression.

  • Environmental stress adaptation: L. pneumophila transitions between environmental amoebae hosts and human macrophages, requiring rapid gene expression changes. RNase III could facilitate these adaptations through post-transcriptional regulation.

  • Integration with other virulence mechanisms: L. pneumophila possesses several important virulence determinants, including:

    • The lag-1 gene, which confers resistance to complement-mediated killing

    • The rcp gene, which provides resistance to cationic antimicrobial peptides

    • The Dot/Icm type IV secretion system effectors

RNase III may interact with these pathways through direct regulation of their transcripts or through broader effects on stress response pathways.

What insights can comparative genomics provide about Ribonuclease III conservation and evolution among Legionella species?

Comparative genomics approaches offer valuable insights into the evolution and specialization of RNase III:

  • Conservation across Legionella species: Analysis of homologous recombination in L. pneumophila has identified genomic "hotspots" that include regions containing outer membrane proteins, LPS regions, and Dot/Icm effectors . Understanding where the rnc gene falls relative to these hotspots could indicate selective pressures on this enzyme.

  • Horizontal gene transfer: The possibility of horizontal exchange between major clades has been identified as a critical factor in the emergence of clinically important sequence types of L. pneumophila . This raises questions about whether RNase III variants might be transferred between strains.

  • Subspecies differences: Recombination barriers have been observed between L. pneumophila subspecies pneumophila and subspecies fraseri , which may extend to differences in RNase III structure or function.

  • Mutational analysis: Studies examining catalytic residues in RNase III have confirmed conservation of the catalytic mechanism characteristic of this enzyme family , suggesting functional constraints despite potential sequence variation.

What potential does Ribonuclease III have as a therapeutic target for Legionella pneumophila infections?

Considering the essential role of RNase III in RNA processing and gene regulation, it represents a potential therapeutic target:

Advantages as a Target:

  • Essential function in RNA metabolism and gene expression

  • Conserved catalytic mechanism that can be targeted by inhibitors

  • Potential role in pathogen adaptation to host environments

Target Validation Approaches:

  • Conditional knockout studies to confirm essentiality

  • Chemical genetic approaches to identify vulnerabilities

  • Structure-based drug design targeting the catalytic domain

Therapeutic Development Considerations:

  • Selectivity over human RNase III-like enzymes (Drosha, Dicer)

  • Penetration into macrophages where L. pneumophila replicates

  • Combination with existing antibiotics that target different cellular processes

Experimental Testing:

  • J774.1 macrophage infection models for initial screening

  • Murine pulmonary legionellosis models for in vivo validation

  • Assessment of effects on antibiotic resistance development

How do research findings on Legionella pneumophila Ribonuclease III compare with other bacterial pathogens?

Comparative studies provide important context for understanding the unique and shared features of L. pneumophila RNase III:

  • Functional conservation: Studies have demonstrated that RNase III from Campylobacter jejuni can complement an RNase III-deficient E. coli strain in 30S rRNA maturation and PNPase regulation , suggesting broad conservation of core functions across bacterial species.

  • Mechanistic similarities with Salmonella: In Salmonella, RNase III cleaves the small non-coding RNA MicA when hybridized with its mRNA target, resembling the eukaryotic RNA interference process . This mechanism may be shared with L. pneumophila.

  • Species-specific adaptations: Despite functional conservation, peculiarities in RNase III activity have been observed across species, suggesting adaptation to specific ecological niches and lifestyles .

  • Integration with other ribonucleases: The relationship between RNase III and other RNA-processing enzymes varies between bacteria. In L. pneumophila, the presence of RNase R as the only hydrolytic 3'–5' exoribonuclease creates a distinct RNA metabolism landscape compared to bacteria with more diverse exoribonuclease repertoires.

What are the most promising approaches for elucidating the complete targetome of Legionella pneumophila Ribonuclease III?

To comprehensively identify the RNA targets of L. pneumophila RNase III, several cutting-edge approaches should be considered:

  • RNA-seq of wildtype vs. RNase III mutants: Comparative transcriptomics can identify transcripts affected by RNase III deletion, though this won't distinguish direct from indirect effects.

  • CLIP-seq (Crosslinking Immunoprecipitation-Sequencing): This technique can identify RNAs directly bound by RNase III in vivo.

  • Nanopore direct RNA sequencing: This approach can identify changes in RNA modification patterns and structures dependent on RNase III.

  • Structure probing methods: Techniques like SHAPE-seq (Selective 2'-Hydroxyl Acylation analyzed by Primer Extension) can identify RNA structural changes in the presence and absence of RNase III.

  • Ribosome profiling: This can determine how RNase III-mediated RNA processing affects translation efficiency of different mRNAs.

These approaches, especially when used in combination, would provide unprecedented insight into the regulatory networks controlled by RNase III in L. pneumophila.

How might temperature-dependent RNA processing by Ribonuclease III affect Legionella pneumophila infection dynamics?

Temperature-dependent effects could be particularly relevant for L. pneumophila as a pathogen that transitions between environmental and host temperatures:

  • Precedent in RNase R: Research has shown that at lower temperatures, loss of RNase R in L. pneumophila results in the accumulation of structured RNA degradation products and affects gene regulation, specifically increasing expression of the competence regulon .

  • Potential research approaches:

    • Compare RNase III activity and substrate specificity at environmental (~25°C) versus human body temperature (37°C)

    • Identify temperature-sensitive RNA structures that might be preferentially processed by RNase III under different conditions

    • Examine how temperature affects the interplay between RNase III and other ribonucleases in coordinating gene expression

Understanding these temperature-dependent effects could provide insight into how L. pneumophila adapts during the transition from environmental reservoirs to human hosts during infection.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.